Progress in fighting cancer and infections with T cell therapy

The quest to bring immunotherapy into widespread clinical use against cancer and infectious diseases has made great strides in recent years. For example, clinical trials of adoptive T cell therapy are yielding highly promising results. The latest progress is being reported at AAAS 2016 by three international leaders in the field: Professor Dirk Busch, Technical University of Munich; Professor Chiara Bonini, San Raffaele Scientific Institute; and Professor Stanley Riddell, Fred Hutchinson Cancer Research Center. —> Read More